Pacira BioSciences, Inc. (PCRX)
NASDAQ: PCRX · Real-Time Price · USD
25.12
+0.21 (0.84%)
At close: May 9, 2025, 4:00 PM
24.46
-0.66 (-2.63%)
After-hours: May 9, 2025, 4:07 PM EDT
Pacira BioSciences Analyst Ratings
Total Analysts
9
Consensus Rating
Buy
Price Target
$29.89
Upside
+18.99%
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Needham | Needham | Strong Buy Maintains $32 → $30 | Strong Buy | Maintains | $32 → $30 | +19.43% | May 9, 2025 |
| Needham | Needham | Strong Buy Reiterates $32 | Strong Buy | Reiterates | $32 | +27.39% | Apr 8, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $48 → $65 | Strong Buy | Maintains | $48 → $65 | +158.76% | Apr 8, 2025 |
| Barclays | Barclays | Buy Maintains $17 → $24 | Buy | Maintains | $17 → $24 | -4.46% | Feb 28, 2025 |
| Needham | Needham | Strong Buy Maintains $30 → $32 | Strong Buy | Maintains | $30 → $32 | +27.39% | Feb 28, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $57 → $70 | Strong Buy | Maintains | $57 → $70 | +178.66% | Feb 28, 2025 |
| Truist Securities | Truist Securities | Strong Sell → Hold Upgrades $8 → $25 | Strong Sell → Hold | Upgrades | $8 → $25 | -0.48% | Jan 30, 2025 |
| RBC Capital | RBC Capital | Hold Reiterates $18 | Hold | Reiterates | $18 | -28.34% | Jan 14, 2025 |
| Needham | Needham | Strong Buy Maintains $22 → $30 | Strong Buy | Maintains | $22 → $30 | +19.43% | Jan 13, 2025 |
| Needham | Needham | Strong Buy Maintains $22 → $30 | Strong Buy | Maintains | $22 → $30 | +19.43% | Dec 17, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $39 | Strong Buy | Reiterates | $39 | +55.25% | Dec 4, 2024 |
| Barclays | Barclays | Hold Maintains $25 → $17 | Hold | Maintains | $25 → $17 | -32.32% | Nov 12, 2024 |
| Needham | Needham | Strong Buy Reiterates $22 | Strong Buy | Reiterates | $22 | -12.42% | Nov 8, 2024 |
| RBC Capital | RBC Capital | Hold Maintains $15 → $16 | Hold | Maintains | $15 → $16 | -36.31% | Nov 7, 2024 |
| RBC Capital | RBC Capital | Hold Maintains $14 → $15 | Hold | Maintains | $14 → $15 | -40.29% | Oct 4, 2024 |
| Jefferies | Jefferies | Strong Buy Maintains $15 → $18 | Strong Buy | Maintains | $15 → $18 | -28.34% | Sep 24, 2024 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 10 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.